Skip to content

Profound Medical PROF Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$5.34M-10.7%$5.98M+13.0%$5.29M+139%$2.21M-15.6%$2.62M-37.2%
$1.51M-24.2%$1.99M+46.2%$1.36M+129%$593K-22.8%$768K-36.7%
$3.83M-4.0%$3.99M+1.5%$3.93M+143%$1.62M-12.7%$1.85M-37.4%
71.8%+5.0pp66.8%-7.6pp74.3%+1.1pp73.2%+2.5pp70.7%-0.2pp
$5.26M+23.2%$4.27M-21.2%$5.42M-11.2%$6.1M+26.8%$4.81M+3.4%
$6.59M-7.0%$7.09M-4.6%$7.43M-20.4%$9.33M+13.6%$8.21M+23.3%
$11.85M+4.3%$11.36M-11.6%$12.84M-16.7%$15.42M+18.5%$13.02M+15.1%
-$8.02M-8.8%-$7.37M+17.3%-$8.91M+35.4%-$13.81M-23.6%-$11.17M-33.8%
-150.3%-27.0pp-123.3%+45.2pp-168.5%+456pp-624.4%-198pp-426%-226pp
$377K+136%$160K+31.1%$122K-64.4%$343K-22.9%$445K+34.0%
$993K+227%-$780K-174%$1.06M+158%-$1.83M-478%$483K-84.7%
-$7.03M+13.8%-$8.15M-3.7%-$7.86M+49.7%-$15.63M-46.3%-$10.68M-106%
$25K-3.8%$26K-78.5%$121K+89.1%$64K+56.1%$41K+117%
-$7.05M+13.7%-$8.18M-2.5%-$7.98M+49.2%-$15.7M-46.4%-$10.72M-117%
-132.2%+4.6pp-136.8%+14.0pp-150.8%+559pp-709.9%-301pp-409.2%-291pp
$0.19-29.6%$0.27+3.8%$0.26-50.0%$0.52+44.4%$0.36+100.0%
-$7.92M-9.1%-$7.26M+17.2%-$8.77M+35.9%-$13.67M-24.2%-$11M-35.7%
-148.4%-27.0pp-121.5%+44.3pp-165.7%+452pp-618%-198pp-419.8%-226pp
-$8.02M-8.8%-$7.37M+17.3%-$8.91M+35.4%-$13.81M-23.6%-$11.17M-33.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Profound Medical's revenue?
Profound Medical (PROF) generated $18.8M in revenue over the trailing twelve months, up 58.6% year over year.
Is Profound Medical profitable?
Profound Medical is not currently profitable: it reported a net loss of $38.9M over the trailing twelve months, a -206.8% net margin.
What are Profound Medical's profit margins?
Gross margin is 71.1% and operating margin is -202.6%, with a -206.8% net margin.
What is Profound Medical's earnings per share?
Profound Medical's diluted EPS over the trailing twelve months is $1.24.
Where does Profound Medical's income statement data come from?
Every line is extracted from Profound Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.